Le Lézard
Classified in: Science and technology
Subject: CCA

TERAGO to Reschedule Investor Conference Call to Discuss First Quarter 2024 Financial Results


TORONTO, May 7, 2024 /CNW/ - TERAGO Inc. ("TERAGO" or the "Company") (TSX: TGO) (www.terago.ca), today announced that it has rescheduled its investor conference call to discuss its financial results for the first quarter of 2024 to Wednesday, May 15, 2024, at 5:00 p.m. ET, which was initially scheduled for May 9, 2024. The complete financial results are expected to be released before market open on Wednesday, May 15, 2024.

The Company's quarterly results along with a presentation in connection with the conference call will be made available on the Company's website at https://terago.ca/company/investor-relations/.

To access the conference call, please dial 888-506-0062 or 973-528-0011, and use conference ID 747856 if applicable. Please call the conference telephone number 15 minutes prior to the start time so that you are in the queue for an operator to assist in registering and patching you through.

A replay of the conference call will be available through Wednesday, May 29, 2024, and can be accessed by dialing 877-481-4010 or 919-882-2331 and using passcode 50488.

About TERAGO

TERAGO provides managed network and security services to businesses across Canada ensuring highly secure, reliable and redundant connectivity including private 5G wireless networks, fixed wireless access and fiber and cable wireline network connectivity. As Canada's biggest mmWave spectrum holders, the Company possesses exclusive spectrum licenses in the 24 GHz and 38 GHz spectrum bands, which it utilizes to provide secure, dedicated SLA guaranteed enterprise grade performance that is technology diverse from buried cables ensuring high availability connectivity services. TERAGO serves over 1,900 Canadian and Global businesses operating in major markets across Canada, including Toronto, Montreal, Calgary, Edmonton, Vancouver, Ottawa and Winnipeg, and has been providing wireless services since 1999. For more information about TERAGO, please visit www.terago.ca.

SOURCE TeraGo Inc.


These press releases may also interest you

at 14:15
New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines' ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health awarded Panda Health Partner status for its Orchestral Health Intelligence Platform
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital's Technology Fund I Recognized as Top Performing VC Fund in the Preqin League Tables
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
Industrial Automation Market In Life Sciences Industry size is set to grow by USD 5.06 bn from 2024-2028, growing global demand for healthcare services to boost the market growth, Technavio
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

More news about Science and technology...


News published on and distributed by: